Zabel; Brian A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zabel; Brian A..The latest application filed is for "small molecule cmklr1 antagonists in inflammatory disease".

Company Profile

2.9.13

Zabel; Brian A. - Redwood City CA
Zabel; Brian A. - Redwwod City CA
Zabel; Brian A. - Mountain View CA
Zabel; Brian A. - Stanford CA
Zabel; Brian A. - Dorchester MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
BTLA-binding antibodies for modulating immune response and treating disease Grant 11,384,146 - Zabel , et al. July 12, 2	2022-07-12
Small Molecule Cmklr1 Antagonists In Inflammatory Disease App 20200345661 - Malhotra; Sanjay ; et al.	2020-11-05
Btla-binding Antibodies For Modulating Immune Response And Treating Disease App 20200325230 - Zabel; Brian A. ; et al.	2020-10-15
Methods of enhancing anti-tumor immunity by administering antibodies to the CCRL2 chemerin receptor Grant 9,868,792 - Zabel , et al. January 16, 2	2018-01-16
Mobilizing Anti-tumor Immunity By Targeting Chemerin Receptor Ccrl2 App 20170002087 - Zabel; Brian A. ; et al.	2017-01-05
Small molecule CMKLR1 antagonists in demyelinating disease Grant 9,265,738 - Graham , et al. February 23, 2	2016-02-23
Small Molecule CMKLR1 Antagonists in Demyelinating Disease App 20150025153 - Graham; Kareem ; et al.	2015-01-22
Novel Target for Regulating Multiple Sclerosis App 20120064092 - Graham; Kareem ; et al.	2012-03-15
Target for regulating multiple sclerosis Grant 8,038,992 - Graham , et al. October 18, 2	2011-10-18
Methods For Screening For Modulators Of Ccrl2 App 20100092974 - Zabel; Brian A. ; et al.	2010-04-15
Target For Regulating Multiple Sclerosis App 20090280113 - Graham; Kareem ; et al.	2009-11-12
Methods of treating inflammatory disease using antibodies which bind GPR-9-6 Grant 7,485,301 - Andrew , et al. February 3, 2	2009-02-03
Anti-TECK antibodies and methods of use therefor Grant 7,381,412 - Andrew , et al. June 3, 2	2008-06-03
CMKLR regulation of adipogenesis and adipocyte metabolic function App 20070286863 - Sinal; Christopher ; et al.	2007-12-13
Family of cystatin-related chemoattractant proteins App 20050202029 - Zabel, Brian A. ; et al.	2005-09-15
Anti-TECK antibodies and methods of use therefor App 20050181501 - Andrew, David P. ; et al.	2005-08-18
Methods of identifying agents which inhibit GPR-9-6 Grant 6,884,574 - Andrew , et al. April 26, 2	2005-04-26
Methods of identifying agents which bind GPR-9-6 Grant 6,689,570 - Andrew , et al. February 10, 2	2004-02-10
Methods of identifying agents which inhibit GPR-9-6 App 20030022238 - Andrew, David P. ; et al.	2003-01-30
Methods of treating inflammatory disease using antibodies which bind GPR-9-6 App 20020141991 - Andrew, David P. ; et al.	2002-10-03
Methods of identifying agents which bind GPR-9-6 App 20020119504 - Andrew, David P. ; et al.	2002-08-29
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function Grant 6,329,159 - Andrew , et al. December 11, 2	2001-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.